Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
Sowell Financial Services LLC Sells 8,716 Shares of AbbVie Inc. $ABBV
06:28am, Monday, 29'th Dec 2025
Sowell Financial Services LLC lowered its position in AbbVie Inc. (NYSE: ABBV) by 14.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Mayflower Financial Advisors LLC Buys 3,414 Shares of AbbVie Inc. $ABBV
05:46am, Monday, 29'th Dec 2025
Mayflower Financial Advisors LLC boosted its stake in AbbVie Inc. (NYSE: ABBV) by 21.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Best Dividend Kings: December 2025
06:44am, Sunday, 28'th Dec 2025
Dividend Kings underperformed SPY in 2025, up 4.47% vs. SPY's 17.7%, but select Kings outperformed the index. Twenty-two Dividend Kings are identified as both potentially undervalued and offering long
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of “Moderate Buy” by Brokerages
02:14am, Sunday, 28'th Dec 2025
Shares of AbbVie Inc. (NYSE: ABBV - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-four analysts that are presently covering the firm, MarketBeat Ratings r
2 Dividend Stocks to Double Up On Right Now
03:45pm, Saturday, 27'th Dec 2025
Consumer staples and healthcare can be durable industries to invest in. Costco is highly profitable and relies on its proven membership model.
Is AbbVie a Buy, Sell, or Hold in 2026?
02:30pm, Saturday, 27'th Dec 2025
AbbVie's guidance for the next few years implies robust revenue growth. Some of the company's products are performing even better than expected.
The Best Stocks to Invest $50,000 in Right Now
01:30pm, Saturday, 27'th Dec 2025
Amazon and Alphabet are key leaders in the AI race on top of their flagship businesses. Walmart benefits from consistent non-discretionary spending like groceries.
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio
02:56am, Friday, 26'th Dec 2025
AbbVie headlines today's top stock reports as Zacks highlights pharma recovery, resilient beverages and Chevron???s evolving energy outlook.
AbbVie Inc. $ABBV Shares Purchased by Brookstone Capital Management
05:34am, Thursday, 25'th Dec 2025
Brookstone Capital Management boosted its stake in AbbVie Inc. (NYSE: ABBV) by 25.9% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 97,713 shares of the com
Chatham Capital Group Inc. Has $6.49 Million Stake in AbbVie Inc. $ABBV
04:48am, Thursday, 25'th Dec 2025
Chatham Capital Group Inc. trimmed its holdings in AbbVie Inc. (NYSE: ABBV) by 8.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund
AbbVie Inc. $ABBV Shares Bought by Global X Japan Co. Ltd.
04:48am, Thursday, 25'th Dec 2025
Global X Japan Co. Ltd. increased its position in AbbVie Inc. (NYSE: ABBV) by 587.7% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 25,664 shares of the com
AbbVie Inc. $ABBV Shares Sold by Exchange Traded Concepts LLC
04:08am, Wednesday, 24'th Dec 2025
Exchange Traded Concepts LLC lessened its position in shares of AbbVie Inc. (NYSE: ABBV) by 45.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commiss
ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?
11:56am, Tuesday, 23'rd Dec 2025
AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge.
5 Big Drug Stocks That May Continue to Outperform in 2026
09:51am, Tuesday, 23'rd Dec 2025
Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
2026 Rate Cuts Coming as Inflation Drops: 5 Quality Dividend Stocks to Buy Now
07:42am, Tuesday, 23'rd Dec 2025
When inflation drops, as we saw in the November consumer price index report, the Federal Reserve typically continues to cut interest rates, making fixed-income alternatives less attractive.
